Emerging Technology for Health and Sustainable Development
As an EU Marie Curie Fellow, I worked at the European Commission DG Joint Research Centre's headquarters in Brussels (Belgium) and at Grenoble School of Management (France), to research policies, pathways, and best practices to advance emerging technologies for social and economic impact, with a focus on health, environmental sustainability, and development.
My work at the European Commission was aimed at informing the Commission's policy-making on innovation and technology transfer in Europe, and investing in eco-industry, health and other public interest technologies.
I collaborated with a number of partner organizations that are active in terms of researching, developing, and bringing to market emerging technologies for social and economic impact. Among them were companies such as Intel and Siemens, top European universities such as IE Business School and Rotterdam's Erasmus University, and research labs such as Fraunhofer and CERN.
My work with colleagues from Grenoble-em, Bocconi, and CERN, also conducted research at the intersection of management, sociology, science policy, and philosophy of science and technology. For instance, my colleagues and I carried out a study on particle therapy of cancer, that was later published with Edward Elgar Publishing as part of a book on the management of emerging technologies for socio-economic impact published with other Marie Curie Fellows and faculty.
As my research progressed by using network science and various computational techniques, I inspired (and later helped) CERN to launch Collaboration Spotting, a data analytics platform helping scientific labs and companies to find new technology pathways and R&D collaborators increasing their technology transfer to society. This software is now used in other fields too, such as pharmaceuticals and IT networks, and CERN included CollSpotting among its success stories.